SCHEMBL9047760

SCHEMBL9047760

CC(C)c1ccc(S(=O)(=O)Nc2ncnc(Cl)c2Cc2ccccc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 2/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 3/20 0.37
POLB P06746 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KIT P10721 1/20 0.37
PTGS2 P35354 1/20 0.36
ALOX12 P18054 1/20 0.36
HTR6 P50406 1/20 0.36
PGR P06401 1/20 0.36
ESR1 P03372 1/20 0.36
EDNRB P24530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9046333 0.89 MAPT (0.45) EDNRAMEN1KMT2ARXFP1LMNA
SCHEMBL9048076 0.89 KDM4E (0.49) EDNRAMEN1KMT2ARXFP1LMNA
SCHEMBL9044533 0.88 EDNRA (0.40) EDNRAMEN1KMT2ARXFP1LMNA
SCHEMBL9047103 0.88 EDNRA (0.56) EDNRAMEN1KMT2ARXFP1ALDH1A1
SCHEMBL9046239 0.88 EDNRA (0.40) EDNRAMEN1KMT2ARXFP1LMNA
SCHEMBL9045073 0.84 EDNRA (0.62) EDNRAESR1EDNRB
SCHEMBL9045216 0.81 LMNA (0.49) EDNRAMEN1KMT2ALMNATP53
SCHEMBL9045564 0.79 EDNRA (0.43) EDNRAMEN1KMT2ALMNATP53
SCHEMBL9045300 0.77 EDNRA (0.58) EDNRAMEN1KMT2ARXFP1LMNA
SCHEMBL9047672 0.76 EDNRA (0.53) EDNRAMEN1KMT2ARXFP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed